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Abstract: We report herein the synthesis of the tetradentate thiosemicarbazone ligand bis(4-
N-methyl-thiosemicarbazone)-4,4’-diacetylphenylmethane, which is a suitable precursor in 
supramolecular chemistry for the preparation of helical metal complexes. This molecule has 
been characterized by microanalysis, mass spectrometry, IR and 1H and 13C NMR 
spectroscopies. Its crystal structure has also been analysed. 
 




Thiosemicarbazones represent one class of versatile multidonor ligands,1 which have been 
demonstrated to possess a wide biological activity.2,3 Our group has recently reported that 
tetradentate [SNNS] thiosemicarbazones derived from 1,3-diacetylbencene can act as useful 
building blocks for generating novel supramolecular motifs.4-6 On the other hand, the ligands 
containing the large spacer bisphenylmethane employed by Hannon et al give rise to 
supramolecular structures with interesting properties.7 
Taking into account the versatility of tetradentate tiosemicarbazones and the supramolecular 
structures derived from ligands containing the spacer bisphenylmethane, in this work we try 
to combine both structural factors. With this objective in mind we have synthesized and 
characterized the new ligand bis(4-N-methyl-thiosemicarbazone)-4,4’-diacetylphenylmethane 





The [N2S2] tetradentate tiosemicarbazone ligand 1 has been prepared by treatment of  
4,4’-diacetylphenylmethane (1.00 g, 3.96 mmol) with 4-N-methyl-3-thiosemicarbazide (0.83 
g, 7.92 mmol) in a 1:2 molar ratio, under standard reflux conditions during 24 hours in 
absolute ethanol, in presence of a catalytic quantity of p-toluenesulfonic acid (Scheme 1). 
The removal of the solvent with a Dean-Stark trap gives rise to a yellow powdery solid that 
was satisfactorily characterised as it is shown below. Recrystallization of 1 in acetonitrile 
allows us to obtain crystals of the ligand, which were crystallographically studied.  
 
Ligand 1: M.p. 205 ºC. Yield 1.57 g (93%) Elemental analysis, Calc. for C21H26N6S2: C, 59.13; 
H, 19.70; N, 6.14; S, 15.03. Found: C, 59.11; H, 19.25; N, 5.80; S, 14.70 %. MS ESI- (m/z): 
426.59 ([1]+); IR (KBr, cm-1): ν(N-H) 3365, 3284, 3225, ν(C=N + C-N) 1545, 1493, ν(C=S) 
1105, 818. 1H NMR (DMSO-d6, ppm), δ (m, nH): 10.17 (s, 2H), 8.41 (s, 2H), 7.83 (d, 4H), 







Results and discussion 
This ligand molecule has been obtained with high purity and yield. The crystal structure of 1 
is shown in Figure 2 with the atom-labelling scheme. Main crystallographic data are 
summarised in Table 1. Bond lengths and angles are shown in Table 2, while the hydrogen 
bond parameters are listed in Table 3. 
The crystal structure of 1 consists of discrete molecules with the two thiosemicarbazone 
arms adopting an E conformation in relation to the two imine bonds (Figure 2). As 
expected, this E conformation is mainly determined by the existence of both intra- and 
intermolecular hydrogen bonds (Table 3). 
The imine nitrogen atom and the NH thioamide group of each ligand arm are involved in 
the intramolecular hydrogen bonds giving rise to two five-membered quelate rings per 
ligand.  
The intermolecular hydrogen bonds are established between the thioamide nitrogen atoms 
that are bonded to the sulfur atom of a neighbour molecule. These interactions connect the 





The imine bond distances are 1.287 Å, slightly higher to those expected for conjugated imine 
bonds (1.279 Å). In the case of the thiourea groups the bond distances C-S are in the 
expected range [C=S thiourea (1.681 Å)].8 
Regarding to the 1 arrangement it must be noted that the N/S donor atoms for the ligand 
arms are oriented to opposite directions. For that reason the coordination of these two 
donor atoms to the same metal ion would need a conformational rotation that places the 
imine nitrogen and the thioamide sulfur atoms pointing to the same metal centre. 
Moreover, the introduction of the large and semi-flexible spacer bisphenylmethane in the 
ligand structure guarantees the coordination of each bidentate binding domain [NS] to 




The novel thiosemicarbazone ligand 1 could be obtained with high purity and yield. Its 
crystal structure reveals that donor atoms (nitrogen and sulfur) are oriented to opposite 
directions in the ligand arms. This fact indicates a neccesary conformational rotation in 
order to bind a metal center. Thus, considering the presence of a large and semi-flexible 
spacer and the optimal conformation taken by the free ligand, helical supramolecular 
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Molecular weight 445.14 
Crystal system Monoclinic 
Crystal size /mm 0.40  0.24  0.20 
Volume /Å3 4622.2(3) 









Measured reflexions 34029 
Independent reflexions [Rint] 4881 [0.048] 
R Final index [I>2(I)] 0.0604 [0.1181] 
R index [all data] 0.0454 [0.1114] 
 
 
Table 2  
Bond distances (Å) 
C1-S1 1.688(2) N4-N5 1.377(2) C1-N2 1.360(3) 
C17-S2 1.689(2) N2-N3 1.376(2) N5-C17 1.356(3) 
N3-C2 1.287(3) C16-N4 1.287(3) N1-C20 1.451(3) 
Bond angles (º) 
C2-N3-N2 118.27(17) N1-C1-S1 124.41(17) N5-C17-S2 119.69(16) 




D-H···A D-H (Å) H···A (Å) D···A (Å) D-H···A (<) 
N(1)-H(1N)N(3) 0.83(2) 2.19(3) 2.612(3) 112.0(2) 
N(1)-H(1)S(2)i 0.83(2) 2.84(3) 3.470(2) 135.0(3) 
N(6)-H(6N)N(4) 0.86(3) 2.22(3) 2.612(3) 108.0.(2) 
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